Sort   by:  
 Page size 
TranscriptomicsMicroRNA expression profiling of Igf2-p and H19-m mutant mouse embryos
Changes in microRNA expression in Igf2-p and H19-m mouse embryos (E9.5) were determined in order to assess whether perturbation of miR-483* and miR-675 in Igf2-p and H19-m mutants was likely to have contributed to a modification of tumour phenotype. The Igf2 gene contains miR-483* but the targeted d...
ORGANISM(S): Mus musculus 
2011-12-01 | E-MTAB-873 | biostudies-arrayexpress
TranscriptomicsAnalysis of early primary breast cancer to identify prognostic markers and associated pathways: mRNA and miRNA profiling
This SuperSeries is composed of the following subset Series: GSE22216: microRNA expression profiling of early primary breast cancer to identify prognostic markers and associated pathways GSE22219: Gene expression profiling of early primary breast cancer to identify prognostic markers and associated ...
ORGANISM(S): Homo sapiens 
2011-07-08 | E-GEOD-22220 | biostudies-arrayexpress
TranscriptomicsmicroRNA expression profiling of early primary breast cancer to identify prognostic markers and associated pathways
Retrospective series of primary breast cancer patients who received surgery between 1989 and 1992. Patients received adjuvant chemotherapy and/or adjuvant hormone therapy, or no adjuvant treatment. Tamoxifen was used as endocrine therapy for 5 years in ER+ BC patients. Patients who were <50 years of...
ORGANISM(S): Homo sapiens 
2011-07-08 | E-GEOD-22216 | biostudies-arrayexpress
TranscriptomicsGene expression profiling of early primary breast cancer to identify prognostic markers and associated pathways
Retrospective series of primary breast cancer patients who received surgery between 1989 and 1992. Patients received adjuvant chemotherapy and/or adjuvant hormone therapy, or no adjuvant treatment. Tamoxifen was used as endocrine therapy for 5 years in ER+ BC patients. Patients who were <50 years of...
ORGANISM(S): Homo sapiens 
2011-07-08 | E-GEOD-22219 | biostudies-arrayexpress
TranscriptomicsRegulation of gene expressions in vivo by anti-VEGF therapy
U87-EV human glioblastoma xenograft tumours is therapeutically treated by bevacizumab, a humanized anti-human VEGF mAb, when tumour is established in BALB/c SCID mice. At the end point, collect tumour samples and extracted total RNA for microarray to investigate the gene profile changes compared to ...
ORGANISM(S): Homo sapiens 
2014-04-25 | E-GEOD-37956 | biostudies-arrayexpress
TranscriptomicsRegulation of gene expressions in vivo by anti-VEGF and anti-Notch therapy [HG-U133_Plus_2]
U87-EV human glioblastoma xenograft tumours is therapeutically treated by bevacizumab, a humanized anti-human VEGF mAb, or dibenzazepine (DBZ), when tumour is established in BALB/c SCID mice. At the end point, collect tumour samples and extracted total RNA for microarray to investigate the gene prof...
ORGANISM(S): Homo sapiens 
2014-04-25 | E-GEOD-39223 | biostudies-arrayexpress
TranscriptomicsRegulation of gene expressions in vivo by anti-VEGF and anti-Notch therapy [Mouse430_2]
U87-EV human glioblastoma xenograft tumours is therapeutically treated by bevacizumab, a humanized anti-human VEGF mAb, or dibenzazepine (DBZ) when tumour is established in BALB/c SCID mice. At the end point, collect tumour samples and extracted total RNA for microarray to investigate the gene profi...
ORGANISM(S): Mus musculus 
2014-04-25 | E-GEOD-39413 | biostudies-arrayexpress
TranscriptomicsThe telomeric DNA damage response as a therapeutic target in Idiopathic Pulmonary Fibrosis
Studying the expression profile in lungs of G3 Terc-/- mice, compared to wild-type controls
ORGANISM(S): Mus musculus 
2026-07-10 | E-MTAB-17005 | biostudies-arrayexpress
TranscriptomicsTelomeric DNA damage response activation mediates idiopathic pulmonary fibrosis caused by telomere dysfunction
Lungs from wild type and Terc KO mice, treated with DDR inhibitors
ORGANISM(S): Mus musculus 
2026-07-10 | E-MTAB-14908 | biostudies-arrayexpress
Sort   by:  
 Page size